https://www.indianpharmapost.com/srv-hospitals-and-lokmanya-hospital-launch-centre-for-robotic-orthopaedics-117852022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/asc-therapeutics-gets-green-light-to-advance-gene-therapy-for-hemophilia-a-117982022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/x-chems-noor-shaker-awarded-for-achievements-in-ai-for-drug-discovery-117972022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/namsa-to-acquire-european-based-medanex-clinic-117962022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-approves-cartiheals-implant-for-the-treatment-of-cartilage-and-osteochondral-defects-117952022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/genscript-wins-best-cdmo-award-for-the-third-time-117942022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/sara-gutierrez-joins-shl-as-the-chief-science-officer-117932022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/sun-pharma-gets-exclusive-patent-licence-for-vortioxetine-117922022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/oppi-summit-calls-for-collaboration-across-stakeholders-117912022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/medtronic-commences-praan-registry-for-stroke-patients-117902022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/sanofi-and-igm-biosciences-team-up-to-commercialise-igm-antibody-agonists-117892022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/rotary-club-of-delhi-south-carriers-out-large-scale-relief-work-across-leprosy-colonies-117882022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/ondexxya-approved-in-japan-for-reversal-of-acute-major-bleeds-in-patients-on-factor-xa-inhibitors-117872022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/govt-clears-49-applicants-for-pli-in-bulk-drugs-117862022-03-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/tdb-approves-funding-for-mim-in-medtech-117992022-03-30T00:00:00+05:30always0.9